Objectives: Evaluate the acceptability, ceiling and floor effects, reliability, and known-group validity of the Brazilian version of the Treatment Satisfaction Questionnaire for Medication (TSQM) version 1.4 in patients with hypertension.
Methods: The sample consisted of 300 hypertensive patients undergoing treatment in an outpatient department. The acceptability was evaluated from the items not answered in the TSQM. The reliability of the TSQM was estimated through Cronbach's alpha. Known-group validity tested whether the TSQM discriminates satisfaction between different stages of hypertension, diagnoses of left ventricular hypertrophy, medication adherence, and occurrence of side effects.
Results: The TSQM had high acceptability (99% of participants answered all items). A substantial ceiling effect was found in the side effect (89%) and global satisfaction (29%) subscales. Reliability evaluated with Cronbach's alpha showed values >0.76 in all subscales. Known-group validity was supported with a statistically significant difference in patient satisfaction effectiveness between the hypertension groups and those without left ventricular hypertrophy. Regarding medication adherence, the TSQM was able to discriminate satisfaction in the side effect and global satisfaction subscales. A significantly higher satisfaction was found in all subscales of the TSQM in those patients without side effects.
Conclusions: The TSQM is a reliable and valid questionnaire to be used in Brazilians with hypertension.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vhri.2020.07.578 | DOI Listing |
J Cancer Educ
January 2025
Department of Surgery, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Cancer is a major health challenge globally and in Sri Lanka. Providing comprehensive information to patients is crucial for improving treatment outcomes and patient satisfaction, supported by evidence of its effectiveness in managing cancer pain. EORTC QLQ-INFO25, an information module developed by the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, is aimed at assessing cancer patients' perception of information received during different phases of care.
View Article and Find Full Text PDFHeliyon
November 2024
Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
Background: Metabolic dysfunction associated fatty liver disease (MAFLD) is a highly prevalent non-communicable disease whose prevalence is reaching pandemic proportions. Its implications constitute a major public health concern. To date, no validated tool measures knowledge and attitudes towards MAFLD in young adults in the Middle East and North Africa region.
View Article and Find Full Text PDFBMC Med Educ
January 2025
Department of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan City, 701, Taiwan.
Value Health
December 2024
Department of Health Policy, Corvinus University of Budapest, Hungary, Budapest.
Objectives: The EQ Health and Well Being is a new generic measure that captures constructs beyond health-related quality of life, with a 25-item long form (EQ-HWB) and a shorter 9-item version (EQ-HWB-S). This study aims to assess the psychometric performance of both versions in breast cancer, which is the most prevalent cancer globally, and compare them to other instruments.
Methods: A longitudinal survey in Indonesia (2023-24) with 300 female patients used the EQ-HWB, EQ-5D-5L, Functional Assessment of Cancer Therapy-General (FACT-G, from which FACT-8D was derived), Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS, from which SWEMWBS was derived).
Headache
December 2024
Department of Physical Therapy, University of Florida, Gainesville, Florida, USA.
Objective: To develop and assess the psychometrics of the Chronic Headache Self-Efficacy Scale (CHASE).
Background: Existing scales assess self-efficacy in coping strategies and management of symptoms and triggers but do not measure other important self-efficacy domains, such as performing daily activities and socializing in patients with chronic daily headache (CDH).
Methods: The study had two phases: (i) Development of the 14-item CHASE, with items derived from patients with CDH and a multidisciplinary healthcare team; (ii) longitudinal observational study for psychometric evaluation.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!